About Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi
Clinical Trials at Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi
During the past decade, Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi
According to Clinical.Site data, the most researched conditions in "Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi" are
"Idiopathic Pulmonary Fibrosis" (1 trials), "Sickle Cell Disease" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi" in a lesser frequency.
Clinical Trials Intervention Types at Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi
Most popular intervention types in "Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Crovalimab" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "PRM-151 (Zinpentraxin Alfa)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi
The vast majority of trials in "Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi" are
3 trials for "All" genders.
Clinical Trials Status at Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi
Currently, there are NaN active trials in "Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".